Sadeghi M, Lotfi M, Soltani N, Farmani E, Fernandez J, Akhlaghitehrani S
Cancer Cell Int. 2023; 23(1):284.
PMID: 37986065
PMC: 10661689.
DOI: 10.1186/s12935-023-03133-z.
Chen X, Zhu X, Yan W, Wang L, Xue D, Zhu S
BMC Cancer. 2023; 23(1):755.
PMID: 37582734
PMC: 10426220.
DOI: 10.1186/s12885-023-11264-9.
Zhai S, Li X, Lin T
Comb Chem High Throughput Screen. 2023; 27(2):214-226.
PMID: 36927435
DOI: 10.2174/1386207326666230316103604.
Smok-Kalwat J, Mertowska P, Mertowski S, Smolak K, Kozinska A, Koszalka F
Int J Mol Sci. 2023; 24(2).
PMID: 36675020
PMC: 9861992.
DOI: 10.3390/ijms24021506.
Strycharz J, Wroblewski A, Zieleniak A, Swiderska E, Matyjas T, Rucinska M
Antioxidants (Basel). 2021; 10(1).
PMID: 33445738
PMC: 7828194.
DOI: 10.3390/antiox10010101.
Comp34 displays potent preclinical antitumor efficacy in triple-negative breast cancer via inhibition of NUDT3-AS4, a novel oncogenic long noncoding RNA.
Hao Q, Wang P, Dutta P, Chung S, Li Q, Wang K
Cell Death Dis. 2020; 11(12):1052.
PMID: 33311440
PMC: 7733521.
DOI: 10.1038/s41419-020-03235-w.
Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer.
Garrido-Cano I, Constancio V, Adam-Artigues A, Lameirinhas A, Simon S, Ortega B
Int J Mol Sci. 2020; 21(19).
PMID: 33050096
PMC: 7582935.
DOI: 10.3390/ijms21197427.
: A Novel Oncogenic Target of Lung Adenocarcinoma Regulated by Both Strands of ( and ).
Mizuno K, Tanigawa K, Nohata N, Misono S, Okada R, Asai S
Cells. 2020; 9(9).
PMID: 32932948
PMC: 7564711.
DOI: 10.3390/cells9092083.
Discriminating miRNA Profiles between Endometrioid Well- and Poorly-Differentiated Tumours and Endometrioid and Serous Subtypes of Endometrial Cancers.
Kalinkova L, Kajo K, Karhanek M, Wachsmannova L, Suran P, Zmetakova I
Int J Mol Sci. 2020; 21(17).
PMID: 32842533
PMC: 7504607.
DOI: 10.3390/ijms21176071.
MicroRNA-99a Suppresses Breast Cancer Progression by Targeting FGFR3.
Long X, Shi Y, Ye P, Guo J, Zhou Q, Tang Y
Front Oncol. 2020; 9:1473.
PMID: 32038996
PMC: 6993250.
DOI: 10.3389/fonc.2019.01473.
Identifying Potential miRNAs-Disease Associations With Probability Matrix Factorization.
Xu J, Cai L, Liao B, Zhu W, Wang P, Meng Y
Front Genet. 2020; 10:1234.
PMID: 31921290
PMC: 6918542.
DOI: 10.3389/fgene.2019.01234.
Influence and mechanism of miR-99a suppressing development of colorectal cancer (CRC) with diabetes mellitus (DM).
Zhu P, Liu J, Lu M, Wu G, Lin X, Cai L
Onco Targets Ther. 2019; 12:10311-10321.
PMID: 31819515
PMC: 6885593.
DOI: 10.2147/OTT.S190998.
LncRNA LOXL1-AS1 promotes invasion and proliferation of non-small-cell lung cancer through targeting miR-324-3p.
Xie N, Fei X, Liu S, Liao J, Li Y
Am J Transl Res. 2019; 11(10):6403-6412.
PMID: 31737192
PMC: 6834493.
Long noncoding RNA LINC01296 induces non-small cell lung cancer growth and progression through sponging miR-5095.
Hu X, Duan L, Liu H, Zhang L
Am J Transl Res. 2019; 11(2):895-903.
PMID: 30899389
PMC: 6413248.
The heterogeneity of plasma miRNA profiles in hepatocellular carcinoma patients and the exploration of diagnostic circulating miRNAs for hepatocellular carcinoma.
Bai X, Liu Z, Shao X, Wang D, Dong E, Wang Y
PLoS One. 2019; 14(2):e0211581.
PMID: 30721267
PMC: 6363174.
DOI: 10.1371/journal.pone.0211581.
Expression analysis of lung miRNAs responding to ovine VM virus infection by RNA-seq.
Bilbao-Arribas M, Abendano N, Varela-Martinez E, Reina R, de Andres D, Jugo B
BMC Genomics. 2019; 20(1):62.
PMID: 30658565
PMC: 6339376.
DOI: 10.1186/s12864-018-5416-0.
Phosphorylated Akt1 expression is associated with poor prognosis in cutaneous, oral and sinonasal melanomas.
Soares C, Melo de Lima Morais T, Carlos R, Mariano F, Altemani A, de Carvalho M
Oncotarget. 2019; 9(99):37291-37304.
PMID: 30647870
PMC: 6324666.
DOI: 10.18632/oncotarget.26458.
Biological role and clinical value of miR-99a-5p in head and neck squamous cell carcinoma (HNSCC): A bioinformatics-based study.
Chen Y, Yao J, Qin Y, Hu K, Wu F, Fang Y
FEBS Open Bio. 2018; 8(8):1280-1298.
PMID: 30087832
PMC: 6070648.
DOI: 10.1002/2211-5463.12478.
MicroRNAs associated with therapy of non-small cell lung cancer.
Lu J, Zhan Y, Feng J, Luo J, Fan S
Int J Biol Sci. 2018; 14(4):390-397.
PMID: 29725260
PMC: 5930471.
DOI: 10.7150/ijbs.22243.
Regulation of NCAPG by miR-99a-3p (passenger strand) inhibits cancer cell aggressiveness and is involved in CRPC.
Arai T, Okato A, Yamada Y, Sugawara S, Kurozumi A, Kojima S
Cancer Med. 2018; 7(5):1988-2002.
PMID: 29608247
PMC: 5943442.
DOI: 10.1002/cam4.1455.